Synaptic degradation of cardiac autonomic nerves in streptozotocin-induced diabetic rats

Pathophysiology

Volumn 19, Issue 4, 2012, Pages 299-307

  Sanyal, Shamarendra N ^a   Wada, Tomoyuki ^a   Yamabe, Motoko ^a   Anai, Hirofumi ^a   Miyamoto, Shinji ^a   Shimada, Tatsuo ^b   Ono, Katsushige ^a  

^a OITA UNIVERSITY   (Japan)

^b OITA UNIVERSITY   (Japan)

Author keywords

Autonomic nervous system; DM; Heart rate variability; Streptozotocin; Synapse

Indexed keywords

GLUCOSE; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; AUTONOMIC NEUROPATHY; BODY WEIGHT; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; ELECTROCARDIOGRAPHY; ELECTRON MICROSCOPY; GLUCOSE BLOOD LEVEL; HEART RATE VARIABILITY; MALE; NERVE ENDING; NERVE FUNCTION; NEUROTRANSMISSION; NONHUMAN; OUTCOME ASSESSMENT; PARASYMPATHETIC NERVE; PRIORITY JOURNAL; R WAVE; RAT; REVIEW; RR INTERVAL; SINUS NODE; SYMPATHETIC NERVE; SYNAPSE VESICLE; ULTRASTRUCTURE;

EID: 84868634977     PISSN: 09284680     EISSN: 1873149X     Source Type: Journal    
DOI: 10.1016/j.pathophys.2012.08.002     Document Type: Review

References (36)

1. Hosking D.J., Bennet T., Hampton J.R. Diabetic autonomic neuropathy. Diabetes 1978, 27:1043-1054.
2. Bellavere F., Balzani I., Masi G.D., Carraro M., Carenza P., Cobelli C., Thomaseth K. Power spectral analysis of heart-rate variations improves assessment of diabetic cardiac autonomic neuropathy. Diabetes 1992, 41:633-640.
3. Sayers B.M. Analysis of heart rate variability. Ergonomics 1973, 16:17-32.
4. Akselrod S., Gordon D., Ubel F.A., Shannon D.C., Barger A.C., Cohen R.J. Power spectrum analysis of heart rate fluctuation: a quantitative probe of beat-to-beat cardiovascular control. Science 1981, 213:220-222.
5. Hashimoto M., Kuwahara M., Tsubone H., Sugano S. Diurnal variation of autonomic nervous activity in the rat. Investigation by power spectral analysis of heart rate variability. Journal of Electrocardiology 1999, 32:167-171.
6. Sanyal S.N., Arita M., Ono K. Inhomogeneous derangement of cardiac autonomic nerve control in diabetic rats. Circulation Journal 2002, 66:283-288.
7. Vadlamudi R.V.S.V., McNeill J.H. Effect of experimental diabetes on isolated rat heart responsiveness to isoproterenol. Canadian Journal of Physiology and Pharmacology 1984, 62:124-131.
8. Jackson C.V., McGrath G.M., Tahiliani A.G., Vadlamudi R.V.S.V., McNeill J.H. A functional and ultrastructural analysis of experimental diabetic rat myocardium: manifestation of a cardiomyopathy. Diabetes 1985, 34:876-883.
9. Giudice P.L., Careddu A., Magni G., Quagliata T., Pacifici L., Carminati P. Autonomic neuropathy in streptozotocin diabetic rats: effect of acetyl-l-carnitine. Diabetes Research and Clinical Practice 2002, 56:173-180.
10. Nasir A., Ganguly P.K., Ken S.D., Grant N.P., Pawan K.S., Naranjan S.D. Beneficial effects of verapamil in diabetic cardiomyopathy. Diabetes 1988, 37:936-942.
11. Sanyal S.N., Ono K. Derangement of autonomic nerve control in rat with right ventricular failure. Pathophysiology 2002, 8:197-203.
12. Chiba T. Electron microscopic and histochemical studies on the synaptic vesicles in mouse vas deferens and atrium after 5-hydroxydopamine administration. Anatomical Record 1973, 176:35-48.
13. Kleiger R.E., Miller J.P., Bigger J.T., Moss J.A. Multicenter post-infarction research group, Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. American Journal of Cardiology 1987, 59:256-262.
14. Stein P.K., Bosner M.S., Kleiger R.E., Conger B.M. Heart rate variability: a measure of cardiac autonomic tone. American Heart Journal 1994, 127:1376-1381.
15. Ravenswaaij-Arts C.M.A.V., Kolle L.A.A., Hopman J.C.W., Stoelinga G.B.A., Geijn H.P.V. Heart rate variability. Annals of Internal Medicine 1993, 118:436-447.
16. Fein F.S., Strobeck J.E., Malhotra A., Scheuer J., Sonnenblick E.H. Reversibility of diabetic cardiomyopathy with insulin in rats. Circulation Research 1981, 49:1251-1261.
17. Mori Y., Yokoyama J., Tsuruoka A., Kurata H., Miura J., Nishimura M., Ikeda Y. A new diabetic strain of rat (WBN/Kob) 4th report: immunologic aspects. Journal of the Japan Diabetes Society 1989, 32:517-523.
18. Clarke B.F., Ewing D.J., Campbell I.W. Diabetic autonomic neuropathy. Diabetologia 1979, 17:195-212.
19. Ewing D.J., Campbell I.W., Clarke B.F. Heart rate changes in diabetes mellitus. Lancet 1981, 1:183-186.
20. Bellavere F., Bosello G., Cardone C., Girardello L., Ferri M., Fedele D. Evidence of early impairment of parasympathetic reflexes in insulin dependent diabetics without autonomic symptoms. Diabetes and Metabolism 1985, 11:152-156.
21. Pfeifer M.A., Cook D., Brodsky J., Tice D., Reenan A., Sally S., Halter J.B., Porte D.J.R. Quantitative evaluation of cardiac parasympathetic activity in normal and diabetic man. Diabetes 1982, 31:339-345.
22. 2+ transients and contractile function of rat myocardium. Archives of Biochemistry and Biophysics 2005, 435:166-174.
23. Tsuchida K., Watajima H., Otomo S. Calcium current in rat diabetic ventricular myocytes. American Journal of Physiology 1994, 267:H2280-H2289.
24. Savarese J.J., Berkowitz B.A. β-Adrenergic receptor decrease in diabetic rat hearts. Life Sciences 1979, 25:2075-2078.
25. Ozaki K., Matsuura T., Narama I. Histochemical and morphometrical analysis of skeletal muscle in spontaneous diabetic WBN/Kob rat. Acta Neuropathologica 2001, 102:264-270.
26. McEwen T.A.J., Sima A.A.F. Autonomic neuropathy in BB rat: assessment by improved method for measuring heart-rate variability. Diabetes 1987, 36:251-255.
27. 2+ current in cardiac myocytes of type 1 diabetic Akita mice due to reduced phosphatidylinositol 3-kinase signaling. Diabetes 2007, 56:2780-2789.
28. 2+ current in human atrial myocytes by insulin. Cardiovascular Research 1999, 44:390-397.
29. 2+ current in rat cardiac myocytes. Cardiovascular Research 1999, 42:113-120.
30. Senges J., Brachmann J., Pelzer D., Hasslacher C., Weihe E., Kübler W. Altered cardiac automaticity and conduction in experimental diabetes mellitus. Journal of Molecular and Cellular Cardiology 1980, 12:1341-1351.
31. Howarth F.C., Qureshi M.A. Effects of carbenoxolone on heart rhythm, contractility and intracellular calcium in streptozotocin-induced diabetic rat. Molecular and Cellular Biochemistry 2006, 289:21-29.
32. Howarth F.C., Al-Sharhan R., Al-Hammadi A., Qureshi M.A. Effects of streptozotocin-induced diabetes on action potentials in the sinoatrial node compared with other regions of the rat heart. Molecular and Cellular Biochemistry 2007, 300:39-46.
33. Malone M.A., Schocken D.D., Hanna S.K., Liang X., Malone J.I. Diabetes-induced bradycardia is an intrinsic metabolic defect reversed by carnitine. Metabolism: Clinical and Experimental 2007, 56:1118-1123.
34. McGrath G.M., McNeill J.H. Ultrastrutural study of the effect of insulin dosage on the myocardium of spontaneously diabetic BB rats. Canadian Journal of Physiology and Pharmacology 1987, 65:2212-2218.
35. Nagano M., Dhalla N.S. Cardiopathy in the spontaneously diabetic (BB) rat: evidence for microangiopathy and autonomic neuropathy in the diabetic heart. The Diabetic Heart 1991, 145-157. Raven Press, New York. P. Rösen, U. Kiesel, H. Reinauer, C. Boy, K. Addicks (Eds.).
36. Marliss E.B., Nakhooda A.F., Poussier P., Sima A.A.F. The diabetic syndrome of the 'BB' wistar rat: possible relevance to type 1 (insulin-dependent) diabetes in man. Diabetologia 1982, 22:225-232.